two
sensit
specif
rtpcr
assay
standardis
test
presenc
human
metapneumoviru
total
nasopharyng
aspir
collect
infant
suffer
bronchiol
sinc
octob
june
shown
previous
neg
common
respiratori
virus
examin
matrix
polymeras
viral
gene
show
low
rate
variat
chosen
design
amplif
assay
ensur
genotyp
human
metapneumoviru
could
detect
rtpcr
follow
revers
line
blot
hybridis
develop
viral
polymeras
gene
matrix
gene
rtpcr
assay
subsequ
nest
pcr
carri
assay
similar
sensit
equival
tcid
human
metapneumoviru
strain
use
posit
control
human
metapneumoviru
present
specimen
studi
approach
describ
robust
method
rapid
diagnosi
human
metapneumoviru
also
establish
etiolog
surveil
tool
epidemiolog
studi
base
result
obtain
human
metapneumoviru
infect
madrid
follow
season
pattern
infect
occur
februari
april
respiratori
infect
common
diseas
world
origin
consider
morbid
mortal
special
infant
elderli
monto
virus
caus
acut
respiratori
infect
includ
influenza
virus
respiratori
syncyti
viru
parainfluenza
virus
adenovirus
coronavirus
enterovirus
rhinovirus
macki
among
respiratori
syncyti
viru
major
pathogen
lower
respiratori
tract
infect
infant
young
children
caus
bronchiol
pneumonia
import
rate
hospit
mccarthi
hall
anoth
recent
discov
paramyxoviru
name
human
metapneumoviru
also
associ
respiratori
diseas
children
van
den
hoogen
et
al
caus
infect
similar
produc
respiratori
syncyti
viru
symptom
rang
wheez
fever
sever
cough
bronchiol
even
pneumonia
assist
ventil
requir
sever
case
esper
et
al
sinc
discov
netherland
viru
also
detect
specimen
adult
elderli
immunocompromis
patient
suffer
acut
respiratori
infect
pelleti
et
al
studi
differ
countri
indic
worldwid
circul
human
metapneumoviru
respiratori
specimen
north
south
america
galiano
et
al
china
peiri
et
al
israel
wolf
et
al
australia
nissen
et
al
netherland
van
den
hoogen
et
al
european
countri
maggi
et
al
nicholson
et
al
viazov
et
al
vicent
et
al
xepapadaki
et
al
two
main
human
metapneumoviru
genet
lineag
describ
cocircul
differ
year
sever
geograph
area
biacchesi
et
al
viazov
et
al
role
human
metapneumoviru
paediatr
acut
respiratori
infect
frequent
deciev
due
difficulti
detect
viru
tradit
diagnost
method
isol
cell
cultur
immunofluoresc
assay
enzym
immunoassay
isol
cell
cultur
ineffici
monoclon
antibodi
immunofluoresc
assay
enzym
immunoassay
easili
avail
test
requir
ensur
reliabl
consequ
specif
sensit
molecular
diagnost
method
essenti
achiev
accur
detect
human
metapneumoviru
clinic
specimen
diagnosi
may
help
clinic
manag
patient
may
establish
role
pathogen
respiratori
infect
epidemiolog
behaviour
present
studi
conveni
use
two
rtpcr
base
assay
design
two
differ
highli
conserv
gene
van
den
hoogen
et
al
codifi
matrix
polymeras
viral
protein
evalu
gene
select
ensur
detect
human
metapneumoviru
independ
genet
variat
assay
rtheminestedpcr
rtpcr
follow
revers
line
blot
hybridis
assay
high
specif
sensit
inclus
routin
diagnosi
method
reduc
number
neg
result
presenc
human
metapneumoviru
evalu
respiratori
secret
collect
children
respiratori
diseas
octob
june
madrid
spain
total
nasopharyng
aspir
young
infant
children
present
acut
respiratori
infect
collect
octob
june
hospit
severo
ochoa
paediatr
unit
madrid
spain
isol
cell
cultur
indirect
immunofluorescene
assay
andor
multiplex
rtnestedpcr
coira
et
al
attempt
everi
sampl
order
detect
influenza
virus
respiratori
syncyti
viru
parinfluenza
virus
adenoviru
enterovirus
presenc
human
metapneumoviru
check
aspir
proven
neg
main
respiratori
virus
specimen
collect
ml
viru
transport
medium
mem
gibcobrl
life
technolog
paisley
scotland
penicillin
uml
streptomycin
gml
biowhittak
mycostatin
uml
sigma
bovin
serum
albumin
merck
darmstadt
germani
specimen
analys
respiratori
viru
laboratori
nation
centr
microbiolog
isciii
madrid
spain
test
presenc
respiratori
virus
specimen
frozen
store
c
test
rhesu
monkey
kidney
cell
line
maintain
dmem
biowhittak
belgium
supplement
foetal
bovin
serum
penicillinstreptomycin
icn
biomed
ohio
human
metapneumoviru
strain
inocul
presenc
gml
trypsin
order
prepar
posit
control
amplif
assay
total
nucleic
acid
extract
l
aliquot
nasopharyng
aspir
also
supernat
infect
cell
cultur
use
posit
control
extract
made
use
guanidinium
thiocyan
method
describ
casa
et
al
neg
control
consist
rnase
free
steril
water
also
submit
extract
process
lysi
buffer
includ
molecul
clone
amplifi
product
rna
control
suppli
promega
rtpcr
system
kit
promega
use
intern
control
extract
step
follow
pcr
process
coira
et
al
specif
primer
pair
design
amplifi
highli
conserv
region
human
metapneumoviru
gene
code
matrix
protein
human
metapneumoviru
sequenc
avail
genebank
databas
use
perform
computerassist
align
use
macaw
program
multipl
align
construct
analysi
workbench
ncbi
bethesda
md
primer
evalu
ensur
fit
essenti
criteria
optim
pcr
primer
dieffenbach
et
al
g
c
content
melt
temperatur
length
primer
chosen
analys
use
primerselect
dnastar
inc
madin
wisconsin
primer
use
amplifi
part
gene
rtheminestedpcr
assay
mi
mia
rtpcr
mi
subsequ
heminest
amplif
reaction
conserv
fragment
polymeras
gene
amplifi
use
oligonucleotid
van
den
hoogen
et
al
olignonucleotid
biotinlabel
end
permit
detect
pcr
product
chemiluminisc
specif
probe
design
use
revers
line
blot
hybridis
pcr
product
end
amino
label
revers
transcript
pcr
amplif
gene
detect
carri
singl
tube
use
commerci
kit
qiagen
onestep
rtpcr
kit
qiagen
california
reaction
tube
dispens
mixtur
contain
l
buffer
mm
mgcl
mm
dntp
specif
primer
mi
mia
specif
primer
intern
control
amplif
l
qiagen
onestep
rtpcr
enzym
mix
accord
manufactur
instruct
l
nucleic
acid
extract
final
volum
l
thermal
cycl
condit
follow
rt
proccess
initi
cycl
c
min
c
min
cycl
condit
pcr
cycl
c
c
min
c
final
min
incub
c
min
heminestedpcr
reaction
contain
l
buffer
ii
appli
biosystem
new
jersey
mm
mgcl
appli
biosystem
mm
datp
dgtp
dctp
dttp
amersham
pharmacia
biotech
piscataway
new
jersey
specif
primer
mi
specif
primer
intern
control
amplif
u
taq
dna
polymeras
amplitaq
dna
polymeras
appli
biosystern
total
l
first
reaction
product
ad
final
volum
l
heminest
pcr
sampl
heat
c
min
cycl
condit
cycl
c
c
min
c
min
final
incub
c
min
heminest
pcr
product
analys
electrophoresi
seakem
agaros
gel
contain
gml
ethidium
bromid
trisbor
buffer
specif
size
pcr
product
bp
intern
control
bp
human
metapneumoviru
procedur
prepar
amplifi
specimen
includ
convent
recommend
avoid
contamin
pcr
amplif
product
posit
control
kowk
higuchi
rtpcr
assay
l
gene
amplif
carri
singl
tube
use
qiagen
onestep
rtpcr
kit
qiagen
describ
except
dntp
final
concentr
mm
ten
picomol
specif
oligonucleotid
includ
obtain
pb
size
amplifi
product
antisens
primer
label
biotin
end
get
biotinlabel
pcr
amplif
product
thermal
cycl
condit
follow
initi
cycl
c
min
c
min
follow
cycl
c
c
min
c
final
incub
c
min
revers
line
blot
hybridis
procedur
perform
accord
coira
et
al
briefli
carboxyl
group
biodin
c
blot
membran
pall
biosupport
activ
edac
carbodiimid
pall
gelman
laboratori
michigan
membran
place
miniblott
biometra
germani
specif
probe
human
metapneumoviru
l
gene
dilut
final
concentr
pmoll
mm
nahco
ph
coval
link
activ
membran
remain
activ
ester
membran
hydrolys
incub
naoh
membran
wash
sd
place
miniblott
rotat
c
previou
posit
slot
fill
l
denatur
biotinlabel
pcr
product
dilut
sd
sampl
incub
h
c
wash
membran
treat
streptavidinperoxidas
conjug
roch
indiana
final
membran
wash
sspe
hybridis
pcr
product
detect
chemiluminisc
use
ecl
detect
reagent
amersham
pharmacia
biotech
england
visualis
exposur
light
sensit
film
hyperfiltn
ecl
amersham
posit
specimen
human
metapneumoviru
l
gene
purifi
qiaquick
pcr
purif
kit
qiagen
sequenc
obtain
automat
dna
sequenc
abi
prism
appli
biosystem
use
big
dye
termin
cycl
sequenc
kit
version
appli
biosystem
nucleotid
sequenc
obtain
align
sequenc
publish
previous
use
macaw
program
primer
design
rtpcr
base
assay
amplifi
specif
partial
sequenc
human
metapneumoviru
gene
encod
matrix
polymeras
viral
protein
primer
concentr
anneal
temperatur
thermocycl
paramet
concentr
reaction
compon
probe
hybridis
temperatur
concentr
standardis
experiment
optim
assay
condit
assay
show
concord
result
serial
dilut
human
metapneumoviru
strain
use
posit
control
fig
effici
limit
detect
tcid
assay
specif
method
assay
use
rna
extract
differ
respiratori
virus
influenza
b
c
respiratori
syncyti
viru
b
parainfluenza
adenovirus
enterovirus
fig
sensit
limit
rtpcr
assay
evalu
serial
dilut
correspond
tcid
prototyp
strain
human
metapneumoviru
grown
cell
left
panel
visualis
rtheminestedpcr
assay
matrix
gene
agaros
gel
intern
control
specif
band
indic
right
panel
show
sensit
film
polymeras
rlb
assay
specif
probe
use
triplic
everi
viru
dilut
assay
detect
limit
reach
dilut
correspond
tcid
revers
line
blot
procedur
polymeras
gene
rtheminestedpcr
matrix
gene
valid
use
total
clinic
nasopharyng
aspir
taken
young
infant
number
specimen
collect
per
season
summar
tabl
specimen
total
result
posit
presenc
human
metapneumoviru
rtpcr
assay
nasopharyng
aspir
consid
posit
presenc
human
metapneumoviru
posit
result
viru
obtain
assay
enough
amount
sampl
avail
posit
human
metapneumoviru
result
confirm
sequenc
analysi
number
posit
human
metapneumoviru
sampl
found
higher
season
two
season
although
number
sampl
analys
three
period
rather
similar
tabl
annual
distribut
human
metapneumoviru
posit
specimen
summar
fig
show
peak
viral
detect
februari
april
correspond
maximum
februari
march
season
anoth
march
april
season
although
posit
nasopharyng
aspir
collect
februari
april
human
metapneumoviru
infect
also
detect
specimen
collect
januari
may
june
octob
decemb
lower
rate
nine
posit
specimen
total
nasopharyng
aspir
collect
one
hospit
three
consecut
season
test
previous
main
respiratori
virus
influenza
ac
respiratori
syncyti
viru
group
b
parainfluenza
adenovirus
enterovirus
use
rtpcr
assay
coira
et
al
indirect
immunofluoresc
assay
andor
isol
cell
cultur
number
posit
viru
percentag
obtain
summar
tabl
fig
shown
percentag
human
metapneumoviru
refer
total
nasopharyng
aspir
least
due
fact
neg
sampl
analys
doubl
infect
could
found
acut
respiratori
infect
compris
wide
rang
clinic
pictur
caus
heterogen
group
virus
thu
need
specif
detect
viru
involv
particular
case
includ
discov
recent
human
metapneumoviru
human
coronaviru
van
der
hoek
et
al
sar
coronaviru
drosten
et
al
case
new
virus
human
metapneumoviru
special
difficult
grow
cell
cultur
reason
molecular
amplif
method
valuabl
tool
detect
viral
rna
present
respiratori
secret
kahn
two
highli
specif
sensit
rtpcr
base
assay
detect
human
metapneumoviru
rna
nasopharyng
aspir
design
perform
rapidli
easili
order
identifi
genet
variant
main
human
metapneumoviru
lineag
design
amplif
assay
focus
fragment
two
differ
gene
highli
conserv
use
two
altern
rtpcr
assay
present
advantag
confirm
posit
result
two
independ
gene
also
guarante
decreas
number
fals
posit
result
rtheminestedpcr
matrix
gene
easi
perform
need
high
technolog
requir
revers
line
blot
protocol
viral
polymeras
gene
safe
procedur
sinc
nonradioact
reactiv
use
label
probe
advantag
suitabl
largescal
epidemiolog
screen
usag
probe
increas
specif
assay
experi
method
reliabl
reproduc
contamin
amplifi
product
prevent
care
separ
mixtur
prepar
extract
addit
sampl
rna
amplif
postamplif
area
differ
set
laboratori
coat
pipett
filter
pipett
tip
use
differ
area
assay
valid
examinin
nasopharyng
aspir
complet
cohort
collect
infant
popul
less
year
old
suffer
acut
respiratori
infect
bronchiol
pneumonia
influenza
like
ill
attend
paediatr
unit
hospit
severo
ochoa
madrid
spain
nasopharyng
aspir
suitabl
type
specimen
specif
diagnosi
infect
due
respiratori
virus
specimen
collect
respiratori
viru
circul
season
also
rest
year
result
provid
evid
human
metapneumoviru
account
mani
case
acut
respiratori
infect
children
age
posit
detect
nasopharyng
aspir
studi
analysi
result
suggest
paediatr
respiratori
diseas
due
human
metapneumoviru
may
underestim
due
lack
rapid
sensit
reliabl
diagnost
method
paediatr
unit
incid
studi
associ
human
metapneumoviru
report
lower
rate
infect
correspond
valu
esper
et
al
ijpma
et
al
mackay
et
al
van
den
hoogen
et
al
percentag
obtain
studi
would
similar
report
maggi
et
al
itali
viazov
et
al
germani
also
studi
specimen
infant
less
year
old
research
evalu
children
older
esper
et
al
peiri
et
al
vicent
et
al
wider
age
group
rang
children
adult
stockton
et
al
found
lower
incid
human
metapneumoviru
therefor
result
support
view
human
metapneumoviru
respiratori
syncyti
viru
import
caus
viral
acut
respiratori
infect
children
year
hand
human
metapneumoviru
detect
present
studi
uniqu
pathogen
sampl
test
found
neg
previous
presenc
common
respiratori
virus
type
sampl
also
test
studi
freymouth
et
al
peret
et
al
howev
coinfect
studi
research
conclud
rare
occur
stockton
et
al
vicent
et
al
coinfect
would
numer
diagnosi
techniqu
use
common
respiratori
virus
mainli
cellular
cultur
indirect
immunofluoresc
assay
sensit
pcr
assay
moment
studi
necessari
obtain
real
analysi
respiratori
viru
infect
although
retrospect
studi
epidemiolog
conclus
may
drawn
human
metapneumoviru
posit
specimen
collect
mainli
late
winter
earli
spring
month
posit
case
detect
rest
year
contrast
studi
altern
year
high
low
incid
observ
maggi
et
al
peak
viru
detect
found
februari
april
year
period
besid
onset
respiratori
syncyti
viru
diseas
determin
decemb
januari
peak
human
metapneumoviru
detect
season
data
shown
result
confirm
human
metapneumoviru
circul
primarili
late
winter
earli
spring
end
circul
respiratori
syncyti
viru
falsey
et
al
maggi
et
al
von
linstow
et
al
howev
posit
specimen
human
metapneumoviru
also
found
late
spring
summer
month
peiri
et
al
report
human
metapneumoviru
activ
month
nevertheless
data
relat
summer
month
avail
sinc
studi
examin
sampl
collect
winter
season
relat
age
children
studi
human
metapneumoviru
infect
affect
children
month
age
data
shown
agreement
previou
data
van
den
hoogen
et
al
studi
need
determin
real
incid
human
metapneumoviru
communityacquir
acut
respiratori
infect
young
children
spain
conclus
method
develop
studi
result
obtain
permit
detect
human
metapneumoviru
indic
import
role
pathogen
caus
bronchiol
young
infant
diagnosi
human
metapneumoviru
essenti
reduc
number
respiratori
infect
etiolog
agent
recogn
note
human
metapneumoviru
detect
subgroup
neg
result
total
nasopharyng
aspir
use
specif
molecular
assay
increas
least
number
specimen
viral
agent
could
determin
result
obtain
indic
human
metapneumoviru
taken
account
differenti
diagnosi
acut
respiratori
infect
mainli
distinguish
respiratori
syncyti
viru
infect
rtpcr
base
assay
describ
specif
sensit
rapid
reliabl
diagnosi
human
metapneumoviru
nasopharyng
aspir
